Hadassah Medical Center: Barak Vivian

1.

Meirovitz A, Gross M, Cohen S, Popovtzer A, Barak V. Effect of irradiation on cytokine production in cancer patients. International Journal of Biological Markers [Internet]. 2022;37(4):360–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135535960&doi=10.1177%252f03936155221116388&partnerID=40&md5=89fa4b0eb972a4892b7137c81d21b6e8

2.

Meirovitz A, Baider L, Peretz T, Stephanos S, Barak V. PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics. Anticancer Research [Internet]. 2022;42(11):5487–96. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140810311&doi=10.21873%252fanticanres.16054&partnerID=40&md5=44838ae54022c7f91c8857cb13c83312

3.

Barak V, Kalickman I, Pe’Er J. SIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma. Anticancer Research [Internet]. 2022;42(3):1447–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125428423&doi=10.21873%252fanticanres.15615&partnerID=40&md5=b4b3ca0941292c1a1a9078c9028b14e8

4.

Meirovitz A, Gross M, Leibovici V, Sheva K, Popovzer A, Barak V. Clinical applicability of the proliferation marker thymidine kinase 1 in head and neck cancer patients. Anticancer Research [Internet]. 2021;41(2):1083–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100625800&doi=10.21873%252fANTICANRES.14866&partnerID=40&md5=bd05dccef05c058bcc2c661a9908b11a

5.

Meirovitz A, Baider L, Peretz T, Stephanos S, Barak V. Effect of pentoxifylline on colon cancer patients treated with chemotherapy (Part I). Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Internet]. 2021;43(1):341–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122906976&doi=10.3233%252fTUB-211533&partnerID=40&md5=faa1ba553335c94c58839b105e7890cf

6.

Barak V, Itzkovich D, Einarsson R, Gofrit O, Pode D. Non-invasive detection of bladder cancer by UBC rapid test, ultrasonography and cytology. Anticancer Research [Internet]. 2020;40(7):3967–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087471124&doi=10.21873%252fANTICANRES.14389&partnerID=40&md5=1f290e537a002ba4e4a602708663a9c0

7.

Nicolini A, Barak V, Biava P, Ferrari P, Rossi G, Carpi A. The use of immunotherapy to treat metastatic breast cancer. Current Medicinal Chemistry [Internet]. 2019;26(6):941–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056158617&doi=10.2174%252f0929867325666180209124052&partnerID=40&md5=fc7a4f49712e8b47700994faf7c53071

8.

Filippou PS, Ren AH, Korbakis D, Dimitrakopoulos L, Soosaipillai A, Barak V, et al. Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases. Clinical Chemistry and Laboratory Medicine [Internet]. 2018;56(11):1945–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047491798&doi=10.1515%252fcclm-2018-0139&partnerID=40&md5=d881385094b65f076a8e0d1a4f992cbd

9.

Dahan S, Bragazzi NL, Yogev A, Bar-Gad M, Barak V, Amital H, et al. The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia. Psychiatry Research [Internet]. 2018;268:467–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051661983&doi=10.1016%252fj.psychres.2018.07.041&partnerID=40&md5=9ad90f71d2600d9f53202821f31e412a

10.

Nicolini A, Carpi A, Ferrari P, Morganti R, Mazzotti V, Barak V, et al. An individual reference limit of the serum CEA–TPA–CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer. Cancer Management and Research [Internet]. 2018;10:6879–86. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058958312&doi=10.2147%252fCMAR.S177522&partnerID=40&md5=1dc67ec957c52c3077ccd28ec478203b

11.

Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, et al. Validation of new cancer biomarkers: The official position of the European Group on Tumor Markers [Validazione di nuovi marcatori di neoplasia: La posizione ufficiale dell’"European Group on Tumor Markers]. Biochimica Clinica [Internet]. 2017;41(1):102–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018642007&doi=10.19186%252fBC-2017.12&partnerID=40&md5=c6b811d6f35c244b192afcfacb4447f5

12.

Gross M, Meirovich A, Rachmut J, Kalichman I, Peretz T, Eliashar R, et al. The diagnostic and prognostic value of sIL-2R as an immune biomarker in head and neck cancers. Anticancer Research [Internet]. 2016;36(8):4347–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991777020&partnerID=40&md5=ca892a5af586537759bd6a51d4984175

13.

Barak V, Leibovici V, Peretz T, Kalichman I, Lotem M, Merims S. Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β. Anticancer research [Internet]. 2015;35(12):6755–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973410099&partnerID=40&md5=27fdb24267052896cd937abfa043d064

14.

Barak V, Meirovitz A, Leibovici V, Rachmut J, Peretz T, Eliashar R, et al. The diagnostic and prognostic value of tumor markers (CEA, SCC, CYFRA 21-1, TPS) in head and neck cancer patients. Anticancer Research [Internet]. 2015;35(10):5519–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942779456&partnerID=40&md5=ae1f23cb284c81cd2a13c6e5c45f79d3

15.

Barak V, Pe’er J, Kalickman I, Frenkel S. Erratum: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans (Current Eye Research (2011) 36 (386-390)). Current Eye Research [Internet]. 2015;40(8):862. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84936937514&doi=10.3109%252f02713683.2014.936254&partnerID=40&md5=cfaf489868e77a48c1e0a21c4b5b2727

16.

Landesberg G, Levin PD, Gilon D, Goodman S, Georgieva M, Weissman C, et al. Myocardial dysfunction in severe sepsis and septic shock: No correlation with inflammatory cytokines in real-life clinical setting. Chest [Internet]. 2015;148(1):93–102. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937570546&doi=10.1378%252fchest.14-2259&partnerID=40&md5=4c7e7cf5d2c70edbe4ce70fb7b6e7e95

17.

Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, et al. Validation of new cancer biomarkers: A position statement from the european group on tumor markers. Clinical Chemistry [Internet]. 2015;61(6):809–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930520177&doi=10.1373%252fclinchem.2015.239863&partnerID=40&md5=d2862d26dcca83454a606c0fac720d24

18.

Gatt ME, Goldschmidt N, Kalichman I, Friedman M, Arronson AC, Barak V. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation. Anticancer Research [Internet]. 2015;35(5):3019–26. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929663080&partnerID=40&md5=91b1b40160f6f168bc1e2696a803d6c1

19.

Karlikova M, Topolcan O, Wolfe OTJ, Barak V, Zima T. Optimal Use of Biomarkers in Oncology. BioMed Research International [Internet]. 2015;2015. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939818207&doi=10.1155%252f2015%252f423159&partnerID=40&md5=f44bb05cb75e76b309372cf0b03175d4

20.

Czerninski R, Basile JR, Kartin-Gabay T, Laviv A, Barak V. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: A pilot study. Oral Diseases [Internet]. 2014;20(5):477–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902076780&doi=10.1111%252fodi.12160&partnerID=40&md5=4683ce1db2fa081ed1d4d7b8eae457cd

21.

Arnson Y, Itzhaky D, Mosseri M, Barak V, Tzur B, Agmon-Levin N, et al. Vitamin D inflammatory cytokines and coronary events: A comprehensive review. Clinical Reviews in Allergy and Immunology [Internet]. 2013;45(2):236–47. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884907659&doi=10.1007%252fs12016-013-8356-0&partnerID=40&md5=88eb83df4c6980d5bec0a71ad132a75b

22.

Frenkel S, Zloto O, Pe’er J, Barak V. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans. Investigative Ophthalmology and Visual Science [Internet]. 2013;54(1):490–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874729378&doi=10.1167%252fiovs.12-10228&partnerID=40&md5=eb50fd71189cdcec4326a95940eb1c87

23.

Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, et al. Design of tumor biomarker-monitoring trials: A proposal by the European Group on Tumor Markers. Clinical Chemistry [Internet]. 2013;59(1):52–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872009094&doi=10.1373%252fclinchem.2011.180778&partnerID=40&md5=d5b6b889a21d738a1fc643ee402f5e96

24.

Elbaz M, Yanay N, Aga-Mizrachi S, Brunschwig Z, Kassis I, Ettinger K, et al. Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy 2J/dy 2J mouse. Annals of Neurology [Internet]. 2012;71(5):699–708. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860186068&doi=10.1002%252fana.22694&partnerID=40&md5=7e803e4c04302a15f9aa47ad1b5df986

25.

Sivan S, Suzan F, Rona O, Tamar H, Vivian B, Tamar P, et al. Serum CEACAM1 correlates with disease progression and survival in malignant melanoma patients. Clinical and Developmental Immunology [Internet]. 2012;2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856405473&doi=10.1155%252f2012%252f290536&partnerID=40&md5=df55171fd21d67b96a1a03547dbd039d

26.

Oberbaum M, Spira RM, Lukasiewicz E, Armon Y, Samuels N, Singer SR, et al. Effect of traumeel S on cytokine profile in a cecal ligation and puncture (CLP) sepsis model in rats. Journal of Alternative and Complementary Medicine [Internet]. 2011;17(10):909–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054856888&doi=10.1089%252facm.2011.0205&partnerID=40&md5=55b94ad1f965496278e934d3370803f7

27.

Barak V, Pe’er J, Kalickman I, Frenkel S. VEGF as a biomarker for metastatic uveal melanoma in humans. Current Eye Research [Internet]. 2011;36(4):386–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952760563&doi=10.3109%252f02713683.2010.534573&partnerID=40&md5=d5e5328132ac65ecdd81c03dfa2fd813

28.

Beloosesky Y, Weiss A, Hershkovitz A, Hendel D, Barak V. Serum transforming growth factor beta-1 post hip fracture repair in elderly patients. Cytokine [Internet]. 2011;54(1):56–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952069234&doi=10.1016%252fj.cyto.2010.12.015&partnerID=40&md5=7bf6af790570b752ff3ea8caacd3b1d4

29.

Nicolini A, Conte M, Rossi G, Ferrari P, Duffy M, Barak V, et al. Additional 5-FU-LV significantly increases survival in gastrointestinal cancer. Frontiers in Bioscience - Elite [Internet]. 2011;3 E(4):1475–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053603978&doi=10.2741%252fe348&partnerID=40&md5=8247beef4e4bc96bc625470e2ff68f51

30.

Hendler K, Pe’er J, Kaiserman I, Baruch R, Kalickman I, Barak V, et al. Trends in liver function tests: A comparison with serum tumor markers in metastatic uveal melanoma (Part 2). Anticancer Research [Internet]. 2011;31(1):351–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79851503507&partnerID=40&md5=e73ac8a4a6bd286d6cb454942336638d

31.

Barak V, Kaiserman I, Frenkel S, Hendler K, Kalickman I, Pe’er J. The dynamics of serum tumor markers in predicting metastatic uveal melanoma (Part 1). Anticancer Research [Internet]. 2011;31(1):345–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79851498472&partnerID=40&md5=d4403a877f8322d4f21e1d728eb3d698

32.

Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, et al. Vitamin D: An instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Annals of the Rheumatic Diseases [Internet]. 2011;70(1):145–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650676621&doi=10.1136%252fard.2010.134817&partnerID=40&md5=23ee1523df293508217bb6f03845600d

33.

Arad I, Bar-Oz B, Ergaz Z, Nir A, Barak V. Interleukin-6 and n-terminal pro-brain natriuretic peptide cord blood levels in premature infants: Correlations with perinatal variables. Israel Medical Association Journal [Internet]. 2010;12(7):419–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955063136&partnerID=40&md5=102df797e54ddd7a26a3ab26b46b3a6b

34.

Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Annals of the Rheumatic Diseases [Internet]. 2010;69(6):1155–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953716994&doi=10.1136%252fard.2009.120329&partnerID=40&md5=49a87c40d2bc6355c1c5da1e5b34e858

35.

Dror R, Lederman M, Umezawa K, Barak V, Pe’er J, Chowers I. Characterizing the involvement of the nuclear factorkappa b (NFκB) transcription factor in uveal melanoma. Investigative Ophthalmology and Visual Science [Internet]. 2010;51(4):1811–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951239640&doi=10.1167%252fiovs.09-3392&partnerID=40&md5=4350a6586e9d4d005bab1835c7e5a9d2

36.

Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, Peretz T, et al. Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study. Radiation Oncology [Internet]. 2010;5(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77949881048&doi=10.1186%252f1748-717X-5-16&partnerID=40&md5=459aeac2dcea9cd9a40d9495dddf264d

37.

Vaisman N, Press J, Leibovitz E, Boehm G, Barak V. Short-term effect of prebiotics administration on stool characteristics and serum cytokines dynamics in very young children with acute diarrhea. Nutrients [Internet]. 2010;2(7):683–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952086467&doi=10.3390%252fnu2070683&partnerID=40&md5=1ca2a3033859faf12af31ab9c5dc12e0

38.

Goldschmidt N, Verber A, Neuman T, Kalikhman I, Barak V. Vascular endothelial growth factors (VEGF) as a major parameter for diagnosis and follow up of a patient with POEMS syndrome [POEMS Sendromlu Hastaların Tanı ve İzlemleri Aç?s?ndan Ana Bir Parametre Olan Vasküler Endotelyal B̈ÿme Faktör̈ (VEGF)]. Journal of Neurological Sciences [Internet]. 2010;27(3):348–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78249279649&partnerID=40&md5=d97705b27b9a95372057bcacbb119d80

39.

Barak V, Holdenrieder S, Nisman B, Stieber P. Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer. Cancer Biomarkers [Internet]. 2009;6(3–4):191–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958190279&doi=10.3233%252fCBM-2009-0129&partnerID=40&md5=fc1953ee7706eec3ae4f3a2505c293d4

40.

Nisman B, Biran H, Ramu N, Heching N, Barak V, Peretz T. The diagnostic and prognostic value of ProGRP in lung cancer. Anticancer Research [Internet]. 2009;29(11):4827–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-75149119733&partnerID=40&md5=678933456436fcd6484227247fabc31f

41.

Barak V, Selmi C, Schlesinger M, Blank M, Agmon-Levin N, Kalickman I, et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. Journal of Autoimmunity [Internet]. 2009;33(3–4):178–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-71649095850&doi=10.1016%252fj.jaut.2009.09.010&partnerID=40&md5=9c7dc6120eacf70486120a1f2cf074a7

42.

Nisman B, Yutkin V, Peretz T, Shapiro A, Barak V, Pode D. The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: A pilot study. Anticancer Research [Internet]. 2009;29(10):4281–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-71949119890&partnerID=40&md5=00c67ccac2fde71e0d1953a7bc5836b2

43.

Waknine-Grinberg JH, El-On J, Barak V, Barenholz Y, Golenser J. The immunomodulatory effect of Sambucol on leishmanial and malarial infections. Planta Medica [Internet]. 2009;75(6):581–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949083821&doi=10.1055%252fs-0029-1185357&partnerID=40&md5=f61562361b4a0edde5bd7173c0026b21

44.

Mashiah J, Brenner S, Pessach Y, Barak V, Schachter J. Differences in cytokine levels in melanoma patients with and without redness (Brenner sign). Anticancer Research [Internet]. 2009;29(5):1793–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650093540&partnerID=40&md5=a1162d7242acbba9fa479345da386ad0

45.

Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity. Fertility and Sterility [Internet]. 2009;91(5):1837–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349197629&doi=10.1016%252fj.fertnstert.2008.02.006&partnerID=40&md5=b7a5be4956fbf5855955731878afa8ba

46.

Rott D, Leibowitz D, Finci-Yeheskel Z, Barak V, Chajek-Shaul T, Weiss T, et al. The relationship of plasminogen activator inhibitor-1 levels to the ST deviation pattern of acute myocardial infarction. Cardiology [Internet]. 2008;112(1):56–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-57149118231&doi=10.1159%252f000137700&partnerID=40&md5=6f640ff4a1ae7b19c8625265658f64dd

47.

Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertility and Sterility [Internet]. 2008;89(4):922–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-41749096784&doi=10.1016%252fj.fertnstert.2007.03.097&partnerID=40&md5=b31e7f2268775900383e44eca27ead2a

48.

Nisman B, Biran H, Heching N, Barak V, Ramu N, Nemirovsky I, et al. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: Association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. British Journal of Cancer [Internet]. 2008;98(1):77–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049068376&doi=10.1038%252fsj.bjc.6604157&partnerID=40&md5=b7a836c5377bacebee0f4fa78190da4d

49.

Molina R, Barak V, Van Dalen A, Duffy MJ, Einarsson R, Gion M, et al. Tumor markers in breast cancer - European Group on Tumor Markers (EGTM) recommendations. Internal Medicine Clinical and Laboratory [Internet]. 2007;15–16:29–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-60849135724&partnerID=40&md5=16f05e93effa742e17bba8173a2f92f8

50.

Barak V, Frenkel S, Valyi-Nagy K, Leach L, Apushkin MA, Lin AY, et al. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker. Investigative Ophthalmology and Visual Science [Internet]. 2007;48(10):4399–402. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-35748943863&doi=10.1167%252fiovs.07-0552&partnerID=40&md5=5487121a5918f5a966858d356ce27bcb

51.

Portugal M, Barak V, Ginsburg I, Kohen R. Interplay among oxidants, antioxidants, and cytokines in skin disorders: Present status and future considerations. Biomedicine and Pharmacotherapy [Internet]. 2007;61(7):412–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547790677&doi=10.1016%252fj.biopha.2007.05.010&partnerID=40&md5=4850c9db968a147c5e5db69f7738d2a0

52.

Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, et al. Modeling the behavior of uveal melanoma in the liver. Investigative Ophthalmology and Visual Science [Internet]. 2007;48(7):2967–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548075615&doi=10.1167%252fiovs.06-1522&partnerID=40&md5=e5db1dba4b86a9f66b394a0cef1398d9

53.

Barak V, Frenkel S, Kalickman I, Maniotis AJ, Folberg R, Pe’er J. Serum markers to detect metastatic uveal melanoma. Anticancer Research [Internet]. 2007;27(4 A):1897–900. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250766584&partnerID=40&md5=e49d67e7a758e84d1816bf2081c3a83a

54.

Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, et al. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Israel Medical Association Journal [Internet]. 2007;9(6):479–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250818090&partnerID=40&md5=700e96f1518834690259567fb250b281

55.

Amital H, Barak V, Winkler RE, Rubinow A. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis. Annals of the New York Academy of Sciences [Internet]. 2007;1110:649–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-35748951619&doi=10.1196%252fannals.1423.068&partnerID=40&md5=a246a8aa9c5fb6d88121880c99e72f4c

56.

Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: Prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Annals of the New York Academy of Sciences [Internet]. 2007;1109:385–400. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34848884293&doi=10.1196%252fannals.1398.044&partnerID=40&md5=a3a6333b34ac7b84650ad41d154c9985

57.

Beloosesky Y, Hendel D, Weiss A, Hershkovitz A, Grinblat J, Pirotsky A, et al. Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. Journals of Gerontology - Series A Biological Sciences and Medical Sciences [Internet]. 2007;62(4):420–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250370082&doi=10.1093%252fgerona%252f62.4.420&partnerID=40&md5=581b13f7b62fb505b81b9e27a70994b1

58.

Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: A pilot study. Investigative Ophthalmology and Visual Science [Internet]. 2006;47(3):802–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645386576&doi=10.1167%252fiovs.05-0422&partnerID=40&md5=f99b4abaf5254184a048781e28bebdc1

59.

Nisman B, Heching N, Biran H, Barak V, Peretz T. The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Tumor Biology [Internet]. 2006;27(1):8–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-29244489499&doi=10.1159%252f000090151&partnerID=40&md5=20546e3363222cc3db8aab6541af82ac

60.

Vaisman N, Zaruk Y, Shirazi I, Kaysar N, Barak V. The effect of fish oil supplementation on cytokine production in children. European Cytokine Network [Internet]. 2005;16(3):194–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644693632&partnerID=40&md5=3e8d753052cad991efb18c51f67e9e0d

61.

Reichert F, Barak V, Tarshis M, Prindull G, Tarshis E, Ben-Ishay Z. Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies. European Journal of Haematology [Internet]. 2005;75(1):41–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-21044438307&doi=10.1111%252fj.1600-0609.2005.00436.x&partnerID=40&md5=084634b5126ed2f12b30fb8fb70d0c02

62.

Molina R, Barak V, Van Dalen A, Duffy MJ, Einarsson R, Gion M, et al. Tumor markers in breast cancer - European group on tumor markers recommendations. Tumor Biology [Internet]. 2005;26(6):281–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744523250&doi=10.1159%252f000089260&partnerID=40&md5=9bc87fa9e9253ac5ae7f7d6b42803276

63.

Raveh D, Shemesh O, Ashkenazi YJ, Winkler R, Barak V. Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome. Pediatric Nephrology [Internet]. 2004;19(11):1281–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-7744221493&doi=10.1007%252fs00467-004-1573-2&partnerID=40&md5=0f2ed46065e8d3d8ac05ec846c5947f0

64.

Barak V, Elchalal U, Edelstein M, Kalickman I, Lewin A, Abramov Y. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Fertility and Sterility [Internet]. 2004;82(2):415–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4143125447&doi=10.1016%252fj.fertnstert.2004.03.024&partnerID=40&md5=3bc862a25e48d1d75dedacfcc86f4894

65.

Barak V, Kalickman I, Halperin T, Birkenfeld S, Ginsburg I. PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. European Cytokine Network [Internet]. 2004;15(3):203–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-6344284117&partnerID=40&md5=68a7325ba5eec4ea629439bdd6b7909e

66.

Barak V, Goike H, Panaretakis KW, Einarsson R. Clinical utility of cytokeratins as tumor markers. Clinical Biochemistry [Internet]. 2004;37(7):529–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042598857&doi=10.1016%252fj.clinbiochem.2004.05.009&partnerID=40&md5=fe074a1f5a5256ba3d9ff02ea5fd7493

67.

Vaisman N, Hahn T, Karov Y, Sigler E, Barak Y, Barak V. Changes in cytokine production and impaired hematopoiesis in patients with anorexia nervosa: The effect of refeeding. Cytokine [Internet]. 2004;26(6):255–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942627514&doi=10.1016%252fj.cyto.2004.03.006&partnerID=40&md5=3bdf96f0cef5e742cb14819dd6bb0315

68.

Abramov Y, Ezra Y, Elchalal U, Ben-Shachar I, Fasouliotis SJ, Barak V. Markedly elevated levels of inflammatory cytokines in maternal serum and peritoneal washing during arrested labor. Acta Obstetricia et Gynecologica Scandinavica [Internet]. 2004;83(4):358–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642464701&doi=10.1111%252fj.0001-6349.2004.00271.x&partnerID=40&md5=8fedb428125b0d48fb91739b943234b7

69.

Shapira J, Berenstein-Ajzman G, Engelhard D, Cahan S, Kalickman I, Barak V. Cytokine levels in gingival crevicular fluid of erupting primary teeth correlated with systemic disturbances accompanying teething. Pediatric Dentistry [Internet]. 2003;25(5):441–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-22044458212&partnerID=40&md5=492a73ccfcdf2203489ac37ff496be5f

70.

Vaisman N, Leibovitz E, Dagan R, Barak V. The involvement of IL-6 and IL-8 in acute invasive gastroenteritis of children. Cytokine [Internet]. 2003;22(6):194–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0041343007&doi=10.1016%2fS1043-4666%2803%2900177-7&partnerID=40&md5=c2879d16dbe213f2ebc24ed11e1da2dc

71.

Nisman B, Barak V, Hubert A, Kaduri L, Lyass O, Baras M, et al. Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy. Anticancer Research [Internet]. 2003;23(2 C):1939–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037862057&partnerID=40&md5=81f6b7b19d6f6d92f80e10f3e4ef7e0f

72.

Zahalka MA, Barak V, Traub L, Moroz C. PLIF induces IL-10 production in monocytes: a calmodulin-p38 mitogen-activated protein kinase-dependent pathway. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology [Internet]. 2003;17(8):955–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038661170&doi=10.1096%252ffj.02-0960fje&partnerID=40&md5=15412e04de15dc6333f2f729af06fc44

73.

Scheinowitz M, Heled Y, Chouraqui P, Vered Z, Hayardeni Y, Kotlyar A, et al. Dalteparin sodium (Fragmin®). Administration following acute infarction does not affect myocardial perfusion and function in swine. Cardiovascular Drugs and Therapy [Internet]. 2002;16(4):303–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12244269753&doi=10.1023%252fA%253a1021777825386&partnerID=40&md5=3d7f75ec28f3eb4f3b48662597cc4777

74.

Barak V, Birkenfeld S, Halperin T, Kalickman I. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Israel Medical Association Journal [Internet]. 2002;4(11 SUPPL.):919–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036844434&partnerID=40&md5=ff0c3799f75cc74f38183f466ac7ad16

75.

Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Cancer [Internet]. 2002;94(11):2914–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036604272&doi=10.1002%252fcncr.10565&partnerID=40&md5=d09946182857a6ff4e4c14de29a8950e

76.

Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. The role of inflammatory cytokines in Meigs’ syndrome. Obstetrics and Gynecology [Internet]. 2002;99(5 SUPPL. 1):917–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036224253&doi=10.1016%2fS0029-7844%2801%2901602-7&partnerID=40&md5=9f484cfc90f80d9e5076d055ee60a559

77.

Gavish Z, Pinthus JH, Barak V, Ramon J, Nagler A, Eshhar Z, et al. Growth inhibition of prostate cancer xenografts by halofuginone. Prostate [Internet]. 2002;51(2):73–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036571304&doi=10.1002%252fpros.10059&partnerID=40&md5=0cd8b8fbf73961c4c4e09a2ce1aa5cba

78.

Barak V, Nisman B, Hubert A, Lyass O, Peretz T. Cytokeratins - Clinical utility in breast cancer. Journal of Clinical Ligand Assay [Internet]. 2002;25(1):40–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036520572&partnerID=40&md5=f1e9d358e69b1aaf1dc8a8590a150600

79.

Abrahamov D, Erez E, Tamariz M, Dagan O, Pearl E, Abrahamov Y, et al. Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopulmonary bypass. Pediatric Surgery International [Internet]. 2002;18(1):54–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20244368629&doi=10.1007%252fs003830200012&partnerID=40&md5=4162ce3c9f67f323eeb10562477d9e9d

80.

Weiss L, Barak V, Zeira M, Abdul-Hai A, Raibstein I, Reich S, et al. Cytokine production in linomide-treated NOD mice and the potential role of a Th1/Th2 shift on autoimmune and anti-inflammatory processes. Cytokine [Internet]. 2002;19(2):85–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036382601&doi=10.1006%252fcyto.2002.1956&partnerID=40&md5=821490394ecf28ceaa54c6e7be0afd9b

81.

Zecchina G, Novick D, Rubinstein M, Barak V, Dinarello C, Nagler A. Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants. Journal of Hematotherapy and Stem Cell Research [Internet]. 2001;10(6):769–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035686080&doi=10.1089%252f152581601317210863&partnerID=40&md5=b748fec66cb6aba76aeaa199d941703a

82.

Abramov Y, Schenker JG, Lewin A, Kafka I, Jaffe H, Barak V. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndome. Fertility and Sterility [Internet]. 2001;76(1):51–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034950280&doi=10.1016%2fS0015-0282%2801%2901820-9&partnerID=40&md5=0f1ec9f4f35493d949f6b061cbc0d24a

83.

Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. European Cytokine Network [Internet]. 2001;12(2):290–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034982922&partnerID=40&md5=2c99384f0696beaf67a5d3a20ab8034a

84.

Ben-Ishay Z, Barak V. Bone marrow stromal dysfunction in mice administered cytosine arabinoside. European Journal of Haematology [Internet]. 2001;66(4):230–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035011454&doi=10.1034%252fj.1600-0609.2001.066004230.x&partnerID=40&md5=72febf643d576d3df9260addf818516c

85.

Condiotti R, Zakai YB, Barak V, Nagler A. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Experimental Hematology [Internet]. 2001;29(1):104–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035173693&doi=10.1016%2fS0301-472X%2800%2900617-2&partnerID=40&md5=e1ad45026ea0d7c37133447f9c489953

86.

Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. American Journal of Obstetrics and Gynecology [Internet]. 2001;184(3):354–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035094277&doi=10.1067%252fmob.2001.110028&partnerID=40&md5=c6373354d359d8cb8007fbbe1050486c

87.

Abramov Y, Anteby SO, Fatum M, Fasouliotis SJ, Barak V. The kinetics of leptin in Meigs’ syndrome. Gynecologic Oncology [Internet]. 2001;83(2):316–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034754909&doi=10.1006%252fgyno.2001.6392&partnerID=40&md5=85f322ce411e8cb532a48b74110afca7

88.

Barak V, Nisman B, Hubert A, Lyass O, Kaduri L, Peretz T. Prognostic efficacy of TPS in breast cancer. Journal of Tumor Marker Oncology [Internet]. 2000;15(3):171–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744443340&partnerID=40&md5=ce4eba7df4b3a0a85298e19fc58bb4d3

89.

Nisman B, Heching N, Barak V. Serum tumor markers in resectable and nonresectable non-small cell lung cancer. Journal of Tumor Marker Oncology [Internet]. 2000;15(3):195–206. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0006648237&partnerID=40&md5=cf104ef079adcd4428a14b8de75c252f

90.

Nagler RM, Barak V, Nagler A. Short term systemic effects of head and neck irradiation. Anticancer Research [Internet]. 2000;20(3 A):1865–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033862641&partnerID=40&md5=963455c881e5bc49ff655ab6d518e9cd

91.

Abramov D, Erez E, Dagan O, Abramov Y, Pearl E, Veena G, et al. Increased levels of basic fibroblast growth factor are found in the cross-clamped heart during cardiopulmonary bypass. Canadian Journal of Cardiology [Internet]. 2000;16(3):313–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034113517&partnerID=40&md5=e4db0b3b767d4ac8cfcf5603bacb81f2

92.

Kori M, Barak V, Leibovitz E, Altman Y, Eliraz A, Handzel ZT. Specific in vitro proliferative immune responses and lymphokine production in Ethiopian children with and without tuberculosis. Infection [Internet]. 2000;28(1):42–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033979676&doi=10.1007%252fs150100050010&partnerID=40&md5=1e7f9da4b3012f79cc722af112d3c6fa

93.

Houri-Haddad Y, Soskolne WA, Halabi A, Barak V, Shapira L. Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-α and interferon-γ response, and suppression of interleukin-10. Immunology [Internet]. 2000;99(2):215–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033961399&doi=10.1046%252fj.1365-2567.2000.00965.x&partnerID=40&md5=fd3d66681a7a8f34b8ac8edd4c1f8bd6

94.

Aizman I, Many A, Rosenthal E, Schiby G, Goldberg I, Barak V, et al. Neoplastic cell activation and proliferative response to CD40-ligand characterize recurrent leukemic bouts in an unusual case of low grade lymphoma. Leukemia and Lymphoma [Internet]. 2000;36(5–6):613–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033970342&doi=10.3109%252f10428190009148410&partnerID=40&md5=3cf84484a1256f97cf788f3cbe4b5d9e

95.

Pizov R, Weiss YG, Oppenheim-Eden A, Glickman H, Goodman S, Koganov Y, et al. High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury. Journal of Cardiothoracic and Vascular Anesthesia [Internet]. 2000;14(5):519–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033790721&doi=10.1053%252fjcan.2000.9486&partnerID=40&md5=ead769e40bb7432b2d2625582680f64f

96.

Einarsson R, Barak V. TPS(TM): A cytokeratin serum tumor marker for effective of cancer patients with focus on breast cancer. Journal of Clinical Ligand Assay [Internet]. 1999;22(4):348–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033500098&partnerID=40&md5=ff039c9ab108f9eb604708c43b1c320b

97.

Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, et al. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Research [Internet]. 1999;19(4 C):3549–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033455515&partnerID=40&md5=f896d7f9d0673d80e3e5d93542001c68

98.

Levine J, Barak Y, Chengappa KRN, Rapoport A, Antelman SM, Barak V. Low CSF soluble interleukin 2 receptor levels in acute depression. Journal of Neural Transmission [Internet]. 1999;106(9–10):1011–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032727232&doi=10.1007%252fs007020050219&partnerID=40&md5=90b48211fef558100705d5b0fd61b3b2

99.

Levine J, Barak Y, Chengappa KNR, Rapoport A, Rebey M, Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology [Internet]. 1999;40(4):171–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032718722&doi=10.1159%252f000026615&partnerID=40&md5=d1b9c98199c275eaf021f467ca74eba7

100.

Tomer Y, Barak V, Gilburd B, Shoenfeld Y. Cytokines in experimental autoimmune vasculitis: Evidence for a Th2 type response. Clinical and Experimental Rheumatology [Internet]. 1999;17(5):521–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032857042&partnerID=40&md5=347f17b2c5cc8a94f13e98adecf19260

101.

Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, et al. Cytokines in Gaucher’s disease. European Cytokine Network [Internet]. 1999;10(2):205–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032805835&partnerID=40&md5=4c6281257884f9cbf8d0ccc8b6319ef5

102.

Krause I, Blank M, Levi Y, Koike T, Barak V, Shoenfeld Y. Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clinical and Experimental Immunology [Internet]. 1999;117(1):190–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032974977&doi=10.1046%252fj.1365-2249.1999.00930.x&partnerID=40&md5=f660f2cd68894a49a3281ee19b3a681b

103.

Blank M, Krause I, Goldkorn T, Praprotnik S, Livneh A, Langevitz P, et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis and Rheumatism [Internet]. 1999;42(7):1421–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033508775&doi=10.1002%2f1529-0131%28199907%2942%3a7%3c1421%3a%3aAID-ANR16%3e3.0.CO%3b2-O&partnerID=40&md5=04f32b2b9813884da6ecb49d4c5fa400

104.

Voronov E, Weinstein Y, Benharroch D, Cagnano E, Ofir R, Dobkin M, et al. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1α expression. Cancer Research [Internet]. 1999;59(5):1029–35. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033106120&partnerID=40&md5=48b4860e010915bacc368ae065509e38

105.

Geva E, Amit A, Lessing JB, Lerner-Geva L, Daniel Y, Yovel I, et al. Follicular fluid levels of vascular endothelial growth factor: Are they predictive markers for ovarian hyperstimulation syndrome? Journal of Reproductive Medicine for the Obstetrician and Gynecologist [Internet]. 1999;44(2):91–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033016588&partnerID=40&md5=0d156b29fc3ee093398b3af0c769f8cb

106.

Hirshberg B, Kramer MR, Lotem M, Barak V, Shustin L, Amir G, et al. Chronic eosinophilic pneumonia associated with cutaneous T-cell lymphoma. American Journal of Hematology [Internet]. 1999;60(2):143–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032930652&doi=10.1002%2f%28SICI%291096-8652%28199902%2960%3a2%3c143%3a%3aAID-AJH11%3e3.0.CO%3b2-Q&partnerID=40&md5=d895a98e6106b3d44ee2c6a3341c4dca

107.

Rosen G, Sela MN, Naor R, Halabi A, Barak V, Shapira L. Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola. Infection and Immunity [Internet]. 1999;67(3):1180–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033014671&doi=10.1128%252fiai.67.3.1180-1186.1999&partnerID=40&md5=960e3210ea8ac4a29ae1dee15092b76f

108.

Barak V, Nisman B, Polliack A. The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia. European Journal of Haematology [Internet]. 1999;62(2):71–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032956309&doi=10.1111%252fj.1600-0609.1999.tb01724.x&partnerID=40&md5=b9d7ae242e35bd1734a0f2e07286fe50

109.

Nisman B, Lafair J, Lyass O, Dranitzki-Elhalel M, Barak V. Serum Levels of CEA, SCC, TPS and CYFRA 21-1 in Hemodialysis Patients. Journal of Tumor Marker Oncology [Internet]. 1998;13(2):87–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749825284&partnerID=40&md5=3fd40f9b8d4fbd5ae4b579ffaab8cea7

110.

Nisman B, Lafair J, Lyass O, Dranitzki-Elhalel M, Barak V. Serum Levels of CEA, SCC, TPS and CYFRA 21-1 in Hemodialysis Patients. Journal of Tumor Marker Oncology [Internet]. 1998;13(1):33–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0006705907&partnerID=40&md5=8900e56782b0d279c137c9946590eeff

111.

Blank M, George J, Barak V, Tincani A, Koike T, Shoenfeld Y. Oral tolerance to low dose β2-glycoprotein I: Immunomodulation of experimental antiphospholipid syndrome. Journal of Immunology [Internet]. 1998;161(10):5303–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032533475&partnerID=40&md5=214c8b45c6b7027d0a67b4dedf944dd3

112.

Amital H, Levi Y, Blank M, Barak V, Langevitz P, Afek A, et al. Immunomodulation of murine experimental SLE-like disease by interferon-γ. Lupus [Internet]. 1998;7(7):445–54. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-7844221012&doi=10.1191%252f096120398678920406&partnerID=40&md5=3ceb4a0184e86484fcca0fc96fe9f00a

113.

Nisman B, Barak V, Heching N, Kramer M, Reinus C, Lafair J. Cytokeratin markers in malignant pleural mesothelioma. Cancer Detection and Prevention [Internet]. 1998;22(5):416–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031828286&doi=10.1046%252fj.1525-1500.1998.00053.x&partnerID=40&md5=38ac0a2b936c7e6baeff6e314df59f1a

114.

Nagler A, Bishara A, Brautbar C, Barak V. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation. Cytokines, Cellular and Molecular Therapy [Internet]. 1998;4(3):161–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031665305&partnerID=40&md5=689fb7764cfb2b7b1aabc0f2cabd726e

115.

Barak V, Nisman B, Polliack A, Vannier E, Dinarello CA. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia. European Cytokine Network [Internet]. 1998;9(1):33–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031961101&partnerID=40&md5=a8c092de8efdfa5a0e94df565e4fd143

116.

Bishara A, Malka R, Brautbar C, Barak V, Cohen I, Kedar E. Cytokine production in human mixed leukocyte reactions performed in serum-free media. Journal of Immunological Methods [Internet]. 1998;215(1–2):187–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031719895&doi=10.1016%2fS0022-1759%2898%2900078-7&partnerID=40&md5=f8ac8c121dd4af1a6b56af068cd21012

117.

Nisman B, Lafair J, Heching N, Lyass O, Baras M, Peretz T, et al. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information? Cancer [Internet]. 1998;82(10):1850–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032525120&doi=10.1002%2f%28SICI%291097-0142%2819980515%2982%3a10%3c1850%3a%3aAID-CNCR6%3e3.0.CO%3b2-R&partnerID=40&md5=afe0fbe3bdc14f2404accee1858f6785

118.

Blank M, George J, Fishman P, Levy Y, Toder V, Savion S, et al. Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony- stimulating factor expression. Arthritis and Rheumatism [Internet]. 1998;41(2):224–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031935283&doi=10.1002%2f1529-0131%28199802%2941%3a2%3c224%3a%3aAID-ART6%3e3.0.CO%3b2-W&partnerID=40&md5=2d5f3a9f4b683cbd61fc60ef7584318d

119.

Deutsch E, Nisman B, Kaufman M, Barak V. Cytokine evaluation in throat infections. Annals of Otology, Rhinology and Laryngology [Internet]. 1998;107(8):713–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-7344242644&doi=10.1177%252f000348949810700815&partnerID=40&md5=8bf932cc4cbb196551b60d7adbede6b5

120.

Barak V, Kalickman I, Nisman B, Farbstein H, Fridlender ZG, Baider L, et al. Changes in cytokine production of breast cancer patients treated with interferons. Cytokine [Internet]. 1998;10(12):977–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032468321&doi=10.1006%252fcyto.1998.0378&partnerID=40&md5=05a3b522dce78846aa4bca0b9f4d9a9a

121.

Shapira L, Barak V, Soskolne WA, Halabi A, Stabholz A. Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Advances in dental research [Internet]. 1998;12(2):119–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032196050&doi=10.1177%252f08959374980120010401&partnerID=40&md5=aad3e106eb1afaf5fe29194839602756

122.

Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines. American Journal of Medicine [Internet]. 1998;104(1):40–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031936757&doi=10.1016%2fS0002-9343%2897%2900275-1&partnerID=40&md5=c8933f22e9f0c8c3724ddba178734330

123.

Van Dalen A, Barak V, Cremaschi A, Gion M, Molina R, Namer M, et al. The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease. International Journal of Biological Markers [Internet]. 1998;13(1):10–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031849287&doi=10.1177%252f172460089801300103&partnerID=40&md5=0b0d12202e66d62945c8d06f99fe156a

124.

Barak V, Nisman B, Roisman I, Hubert A, Farbstein H, Baider L, et al. TPS in assessing response to therapy and prognosis of breast cancer patients treated with interferons. Journal of Tumor Marker Oncology [Internet]. 1997;12(4):17–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0001780736&partnerID=40&md5=999b7c8971f8be952a1c219fbd8fe211

125.

Toren A, Barak V, Novick D, Nagler A. Soluble interferon-γ receptor and interferon-γ in patients undergoing allogeneic bone marrow transplantation for hematological malignancies. Cytokines, Cellular and Molecular Therapy [Internet]. 1997;3(3):153–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030866056&partnerID=40&md5=6133c796e9d395b67d63b5f3daa057b8

126.

Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M, et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. International Journal of Cardiology [Internet]. 1997;59(2):133–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030997047&doi=10.1016%2fS0167-5273%2897%2902921-5&partnerID=40&md5=1011fb0deb25ba387402f12eef1c563b

127.

Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease. Experimental Hematology [Internet]. 1997;25(3):238–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030890809&partnerID=40&md5=9ba58c2cd7c3380a3b34f67b30a9a657

128.

Shapira L, Soskolne A, Halabi A, Barak V, Stabholz A. Induction of tumor necrosis factor α and interleukin-1β in subcutaneously implanted chamber by lipopolysaccharide. Journal of Endotoxin Research [Internet]. 1997;4(5):325–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031437193&doi=10.1177%252f096805199700400503&partnerID=40&md5=1df6fcd56b01589e2ddf146a55385aec

129.

Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility [Internet]. 1997;67(2):261–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031019390&doi=10.1016%2fS0015-0282%2897%2981908-5&partnerID=40&md5=40bf06e2e5501bbeaa606d4273018a03

130.

Levy Y, George J, Barak V, Shoenfeld Y. Early detection of recurrent mono-metastases of breast cancer to endocrine tissues by following CEA levels. Oncology Reports [Internet]. 1997;4(3):623–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031006385&doi=10.3892%252for.4.3.623&partnerID=40&md5=51849030deac3a2276d48b33aedb350b

131.

BenEzra D, Maftzir G, Barak V. Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behcet disease. American Journal of Ophthalmology [Internet]. 1997;123(5):593–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030992762&doi=10.1016%2fS0002-9394%2814%2971071-2&partnerID=40&md5=6d4467201e1bcb2eaecc9e2b41244e13

132.

Gilad R, Lampl Y, Eshel Y, Barak V, Sarova-Pinhas I. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. British Journal of Rheumatology [Internet]. 1997;36(2):190–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030859141&doi=10.1093%252frheumatology%252f36.2.190&partnerID=40&md5=c4dd67a863cb6458e5ec035ae57c590f

133.

Peretz T, Kaplan-Denour A, Baider L, Hubert A, Stephanos S, Barak V. Combination of interferon and tamoxifen for patients with advanced breast cancer and negative oestrogen receptors. Breast [Internet]. 1997;6(4):190–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030830244&doi=10.1016%2fS0960-9776%2897%2990572-5&partnerID=40&md5=33ad8711e107c27609c7e0a16a305f1a

134.

Merimsky O, Hareuveni M, Barak V, Sperber F, Eshkol Z, Chaitchik S. Elevated breast cancer serum markers in otherwise healthy women. Oncology Reports [Internet]. 1997;4(4):829–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030749777&doi=10.3892%252for.4.4.829&partnerID=40&md5=b7a9cc12c965c08f77b2dc54ac7098c6

135.

Shapira L, Houri Y, Barak V, Soskolne WA, Halabi A, Stabholz A. Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNfα processing in vitro. Journal of Periodontal Research [Internet]. 1997;32(1 PART 2):183–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030631851&doi=10.1111%252fj.1600-0765.1997.tb01403.x&partnerID=40&md5=6de8f3f2112d825b4ddd10787eb6ccdb

136.

Zandman-Goddard G, George J, Blank M, Levy Y, Yanai P, Halperin T, et al. The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus. Immunology Letters [Internet]. 1996;53(2–3):77–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17044454134&doi=10.1016%2fS0165-2478%2896%2902606-5&partnerID=40&md5=516465105052a6a6555ab6e538960e2f

137.

Shimonovitz S, Hurwitz A, Barak V, Dushnik M, Adashi EY, Anteby E, et al. Cytokine-mediated regulation of type IV collagenase expression and production in human trophoblast cells. Journal of Clinical Endocrinology and Metabolism [Internet]. 1996;81(8):3091–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029835173&doi=10.1210%252fjc.81.8.3091&partnerID=40&md5=5758fd0ee294757180c758c420405423

138.

Levi-Schaffer F, Barkans J, Newman TM, Ying S, Wakelin M, Hohenstein R, et al. Identification of interleukin-2 in human peripheral blood eosinophils. Immunology [Internet]. 1996;87(1):155–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-9044220969&partnerID=40&md5=b9b2d0835b33400979278ecfcbacdc8a

139.

Isaac R, Vivian B, Avraham R, Libson U, Bitterman A, Tamar P, et al. Breast cancer: Screening, detection, tumor markers and surgical management. Journal of Tumor Marker Oncology [Internet]. 1996;11(2):131–55. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749833476&partnerID=40&md5=77552cc213eedb1a780f8eb84d37eb45

140.

Van Dalen A, Heering KJ, Barak V, Peretz T, Cremaschit A, Geroni P, et al. Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changes. Breast [Internet]. 1996;5(2):82–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-15844402488&doi=10.1016%2fS0960-9776%2896%2990126-5&partnerID=40&md5=647d742385a1d0e1fd3fab9b731fc16e

141.

Shapira L, Aubrey Soskolne W, Houri Y, Barak V, Halabi A, Stabholz A. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: Correlation with inhibition of cytokine secretion. Infection and Immunity [Internet]. 1996;64(3):825–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-13344250485&doi=10.1128%252fiai.64.3.825-828.1996&partnerID=40&md5=74f86c3e800334451d8bfc2b1104cc27

142.

Nagler A, Shur I, Barak V, Fabian I. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation. Leukemia Research [Internet]. 1996;20(8):637–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030221693&doi=10.1016%2f0145-2126%2896%2900025-2&partnerID=40&md5=c14cb17d4a9e758cd9629328c84505bd

143.

Yakovlev E, Kalichman I, Pisanti S, Shoshan S, Barak V. Levels of cytokines and collagen type I and type III as a function of age in human gingivitis. Journal of Periodontology [Internet]. 1996;67(8):788–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030202535&doi=10.1902%252fjop.1996.67.8.788&partnerID=40&md5=901f3c147e23ca55e91c8d37f1d1ace7

144.

Shapira L, Houri Y, Barak V, Halabi A, Soskolne WA, Stabholz A. Human monocyte response to cementum extracts from periodontally diseased teeth: Effect of conditioning with tetracycline. Journal of Periodontology [Internet]. 1996;67(7):682–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030184002&doi=10.1902%252fjop.1996.67.7.682&partnerID=40&md5=fce805e622ebe6e43d22a331140e7243

145.

Condiotti R, Slavin S, Barak V, Nagler A. The novel immunomodulator, linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. Leukemia Research [Internet]. 1996;20(1):57–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030041952&doi=10.1016%2f0145-2126%2895%2900110-7&partnerID=40&md5=f4416f91b8739c3f719a2cc46831968f

146.

Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JJ, et al. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertility and Sterility [Internet]. 1996;66(1):66–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029950798&doi=10.1016%2fs0015-0282%2816%2958389-7&partnerID=40&md5=d98115f189648556a2b4a620c336ee22

147.

Vaisman N, Barak Y, Hahn T, Karov Y, Malach L, Barak V. Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatric Research [Internet]. 1996;40(1):108–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029889386&doi=10.1203%252f00006450-199607000-00019&partnerID=40&md5=3320ca2a2384b27a2338def19d1d3a1a

148.

Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Human Reproduction [Internet]. 1996;11(7):1381–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029832247&doi=10.1093%252foxfordjournals.humrep.a019404&partnerID=40&md5=3d18e1cf87bff842e3d46d82d546aac9

149.

Deutsch VR, Eldor A, Olson T, Barak V, Pick M, Nagler A. Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis. Medical Oncology [Internet]. 1996;13(1):31–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029815924&doi=10.1007%252fBF02988839&partnerID=40&md5=686bcaf6e51f23b22e90ce7b70624f2e

150.

Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V. Increased serum concentrations of interleukin-1β in patients with coronary artery disease. Heart [Internet]. 1996;76(1):24–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029792534&doi=10.1136%252fhrt.76.1.24&partnerID=40&md5=821f83a25a55b370695018c058d941e6

151.

Nagler A, Or R, Nisman B, Kalickman I, Slavin S, Barak V. Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplantation [Internet]. 1995;60(9):943–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028791694&doi=10.1097%252f00007890-199511150-00011&partnerID=40&md5=89af350571586a269b7ffba847cb00de

152.

Barak V, Roisman I, Kaufman B. Utility of Ca 19-9 tumor marker in pancreatic carcinoma. Harefuah [Internet]. 1995;129(5–6):217–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029364034&partnerID=40&md5=402b68bebf1b89b2b94433e6939b561a

153.

Wieder R, Barak V, Ben-Ishay Z. High-Efficiency Retroviral Gene Transfer into Murine High-Proliferative-Potential Cells Cycle-Activated by Cytosine Arabinoside. Human Gene Therapy [Internet]. 1995;6(7):865–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028984811&doi=10.1089%252fhum.1995.6.7-865&partnerID=40&md5=e30281e8f7e6a9407b644131e8ae3dec

154.

Geva E, Gottesman G, Lemer-Geva L, Lang R, Pomeranz M, Barak V, et al. Secondary amenorrhoea due to persistent corpus luteum in brucellosis. The Lancet [Internet]. 1995;345(8943):201. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028831488&doi=10.1016%2fS0140-6736%2895%2990211-2&partnerID=40&md5=94ade6aa640c49ee00e49aabd6436aec

155.

Leibovici L, Evron R, Axelrod O, Westerman M, Shalit M, Barak V, et al. Imbalance of immune responses in patients with chronic and widespread fungal skin infection. Clinical and Experimental Dermatology [Internet]. 1995;20(5):390–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029585628&doi=10.1111%252fj.1365-2230.1995.tb01355.x&partnerID=40&md5=50ffa3c528ba198f5d9ff9ae0d428160

156.

Barak V. Soluble cytokine receptors in disease. Israel Journal of Medical Sciences [Internet]. 1995;31(9):565–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029090658&partnerID=40&md5=0e311b7b6e1fefaf2700596e2b50df9c

157.

Abramov Y, Galun E, Granat M, Barak V, Abramov D, Plotkin V, et al. Postpartum systemic capillary leak syndrome: a possible etiology. Acta Obstetricia et Gynecologica Scandinavica [Internet]. 1995;74(5):395–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029072980&doi=10.3109%252f00016349509024437&partnerID=40&md5=1abe26601c98837a1e8c6d4d0f6a8e41

158.

Pode D, Shapiro A, Lebensart P, Meretyk S, Katz G, Barak V. Screening for prostate cancer. Israel Journal of Medical Sciences [Internet]. 1995;31(2–3):125–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029062485&partnerID=40&md5=ae4ed01ded855e27a872da3ddf240caf

159.

Barak V. Cytokines and soluble cytokine receptors in Behcet’s disease. Israel Journal of Medical Sciences [Internet]. 1995;31(6):374–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029029488&partnerID=40&md5=9b784975acf32c2ec4653757760adfdd

160.

Barak V, Schaffer FL, Nisman B, Nagler A. Cytokine dysregulation in chronic graft versus host disease. Leukemia and Lymphoma [Internet]. 1995;17(1–2):169–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028968150&doi=10.3109%252f10428199509051718&partnerID=40&md5=e2b2bea31a744b87e1c0365f21b3b420

161.

Edelmann DZ, Peretz T, Barak V, Anteby SO. Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancer. International Journal of Gynecological Cancer [Internet]. 1995;5(6):443–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028860633&doi=10.1046%252fj.1525-1438.1995.05060443.x&partnerID=40&md5=e52c115944560ee396ae50ce76067b44

162.

Barak V, Nisman B, Roisman I, Barak Y, Levine J. Changes in interleukin-1 β and soluble interleukin-2 receptor levels in csf and serum of schizophrenic patients. Journal of Basic and Clinical Physiology and Pharmacology [Internet]. 1995;6(1):61–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028810366&doi=10.1515%252fJBCPP.1995.6.1.61&partnerID=40&md5=d43e03f02b68f8f2156f724bce040ec1

163.

Dann EJ, Gillis S, Rachmilewitz EA, Barak V, Cass Y, Ruchlemer R, et al. Hairy cell leukemia: Results of 2-chlorodeoxyadenosine therapy in Jerusalem. Leukemia and Lymphoma [Internet]. 1994;14(SUPPL. 1):127–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028038028&partnerID=40&md5=3b24e0acb881bb9a6cebf018ef2a2f60

164.

Shapira L, Smidt A, Van Dyke TE, Barak V, Soskolne AW, Brautbar C, et al. Sequential manifestation of different forms of early-onset periodontitis. A case report. Journal of periodontology [Internet]. 1994;65(6):631–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028453778&doi=10.1902%252fjop.1994.65.6.631&partnerID=40&md5=8e5e988d823e47292f8e211e7693b95c

165.

Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V. The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. Journal of periodontology [Internet]. 1994;65(2):139–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028379493&doi=10.1902%252fjop.1994.65.2.139&partnerID=40&md5=f35082081610d337d9d0cbbad784d7c1

166.

Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, et al. Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Research in Immunology [Internet]. 1994;145(2):93–100. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028348696&doi=10.1016%2fS0923-2494%2894%2980019-7&partnerID=40&md5=ea25b78ee2b7c0b390ce39c1e9f163be

167.

Shimonovitz S, Barak V, Zacut D, Ever-hadani P, Chetrit AB, Ron M. High concentration of soluble interleukin-2 receptors in ejaculate with low sperm motility. Human Reproduction [Internet]. 1994;9(4):653–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028325273&doi=10.1093%252foxfordjournals.humrep.a138565&partnerID=40&md5=944048bbc1da3cdcf4ae5d40aefb61aa

168.

Hahn T, Shulman LM, Ben-Hur H, Karov Y, Barak V, Handgretinger R, et al. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor. Experimental Hematology [Internet]. 1994;22(2):114–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028284886&partnerID=40&md5=2b0e9613d3d02b9624db65c857977d71

169.

Engelhard D, Singer R, Nagler A, Barak V. Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after t-lymphocyte depleted bone marrow transplantation for hematological neoplasias. Leukemia and Lymphoma [Internet]. 1994;12(3–4):273–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028226496&doi=10.3109%252f10428199409059599&partnerID=40&md5=136c79f50bb02a0fb2c84b461bd59884

170.

Nagler A, Ackerstein A, Barak V, Slavin S. Treatment of Chronic Myelogenous Leukemia with Recombinant Human Interleukin-2 and Interferon-α2a. Journal of Hematotherapy [Internet]. 1994;3(1):75–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028145693&doi=10.1089%252fscd.1.1994.3.75&partnerID=40&md5=071cbeb35a08241d5bd205c9091d4402

171.

Barak V, Ben-Ishay Z. Cytokine and growth factor gene expression by bone marrow stroma of mice with damaged hematopoiesis and during regeneration. Leukemia Research [Internet]. 1994;18(10):733–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028128385&doi=10.1016%2f0145-2126%2894%2990054-X&partnerID=40&md5=d137cd3371471bb1b05cfdcc26ba657f

172.

Barak V, Nisman B, Dann EJ, Kalickman I, Ruchlemer R, Bennett MA, et al. Serum interleukin 1β levels as a marker in hairy cell leukemia: Correlation with disease status and sIL-2R levels. Leukemia and Lymphoma [Internet]. 1994;14(SUPPL. 1):33–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028027019&partnerID=40&md5=e7470c4046f5bd3a236f68bfabddfab9

173.

Fibach E, Rigel M, Peled T, Treves AJ, Barak V. The effect of human myelomonocytic leukemic cell line (m20) derived IL-1 inhibitor on human erythroid cell development. Leukemia and Lymphoma [Internet]. 1994;15(3–4):327–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027967762&doi=10.3109%252f10428199409049731&partnerID=40&md5=1b00711bd3962c9f7a42d116e179fb9a

174.

Barak V, Peritt D, Yanai P, Halperin T, Treves AJ. In vivo anti inflammatory effects of the M20 IL-1 Inhibitor: I. Effects on acute inflammatory parameters. Biotherapy [Internet]. 1993;6(4):263–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027849581&doi=10.1007%252fBF01878355&partnerID=40&md5=5c694c515aa59a4e2564d207c9d7d592

175.

Barak V, Gorodetsky R, Weidenfeld J, Peritt D, Yanai P, Halperin T, et al. In vivo anti-inflammatory effects of the M20 IL-1 Inhibitor: II. Effects on serum reactants. Biotherapy [Internet]. 1993;6(4):271–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027842787&doi=10.1007%252fBF01878356&partnerID=40&md5=865ff14811826b231d928ceaea870869

176.

Shapira L, Takashiba S, Kalmar JR, Van Dyke TE, Barak V, Aubrey Soskolne W. Rapid fluorometric quantificaition of monocyte attachment in tissue culture wells. Journal of Immunological Methods [Internet]. 1993;165(1):93–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027503953&doi=10.1016%2f0022-1759%2893%2990110-S&partnerID=40&md5=68ededb0a6b83f76f2b727cd3f60a4ff

177.

BenEzra D, Maftzir G, Kalichman I, Barak V. Serum levels of interleukin-2 receptor in ocular Behcet’s disease. American Journal of Ophthalmology [Internet]. 1993;115(1):26–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027471889&doi=10.1016%2fS0002-9394%2814%2973520-2&partnerID=40&md5=991eb5316a30a6d9a4f12f5695d8278d

178.

Putterman C, Barak V, Caraco Y, Neuman T, Shalit M. Episodic angioedema with eosinophilia: A case associated with T cell activation and cytokine production. Annals of Allergy [Internet]. 1993;70(3):243–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027406113&partnerID=40&md5=a19ea6c189a9aef4831375f6e1d688e6

179.

Barak V, Peritt D, Flechner I, Sherman Y, Okon E, Yanai P, et al. The M20 IL-1 inhibitor prevents onset of adjuvant arthritis. Biotherapy [Internet]. 1992;4(4):317–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026606141&doi=10.1007%252fBF02172662&partnerID=40&md5=a570fe87a212d502a8fb59f2e1dd3c13

180.

Peritt D, Flechner I, Yanai P, Okunev E, Halperin T, Treves AJ, et al. The M20 IL-1 inhibitor. II. Biological characterization. Journal of Immunological Methods [Internet]. 1992;155(2):167–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026471298&doi=10.1016%2f0022-1759%2892%2990283-Y&partnerID=40&md5=e5b30bef0369ae97915a49ffb14a9dfe

181.

Peritt D, Flechner I, Okunev E, Yanai P, Halperin T, Treves AJ, et al. The M20 IL-1 inhibitor. I. Purification by preparative isoelectric focusing in free solution. Journal of Immunological Methods [Internet]. 1992;155(2):159–65. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026448534&doi=10.1016%2f0022-1759%2892%2990282-X&partnerID=40&md5=c323a018f368e7abb83cb16c153c63c6

182.

Gofrit O, Pode D, Gez E, Pfau A, Roizman I, Lifshitz Y, et al. Prostatic specific antigen for detection and monitoring of prostatic cancer. Harefuah [Internet]. 1992;122(6):345–8, 408. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027119901&partnerID=40&md5=da854f6495c65368c827c497d62a7c5e

183.

Barak V, Mordel N, Zajicek G, Kalichman I, Treves AJ, Laufer N. The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients. Human Reproduction [Internet]. 1992;7(7):926–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026768761&doi=10.1093%252foxfordjournals.humrep.a137772&partnerID=40&md5=bc915877a4d901dcd289c805d3407174

184.

Barak V, Yanai P, Treves AJ, Roisman I, Simon A, Laufer N. Interleukin-1: Local production and modulation of human granulosa luteal cells steroidogenesis. Fertility and Sterility [Internet]. 1992;58(4):719–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026756044&doi=10.1016%2fS0015-0282%2816%2955318-7&partnerID=40&md5=f214c116b5e9a7f50cd414dd313f9432

185.

Rotshenker S, Aamar S, Barak V. Interleukin-1 activity in lesioned peripheral nerve. Journal of Neuroimmunology [Internet]. 1992;39(1–2):75–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026753607&doi=10.1016%2f0165-5728%2892%2990176-L&partnerID=40&md5=a2a832b33ee820eb5185b605dc851802

186.

Barak V, Kalickman I, Polliack A, Ginzburg M. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-hodgkin’s lymphoma and chronic lymphocytic leukemia. Leukemia and Lymphoma [Internet]. 1992;7(5–6):431–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026743176&doi=10.3109%252f10428199209049799&partnerID=40&md5=d1d0c187795db665c93f15a4d30f26a4

187.

Isacson R, Kedar E, Barak V, Gazit Z, Yurim O, Kalichman I, et al. Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response. Immunology Letters [Internet]. 1992;33(2):127–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026719884&doi=10.1016%2f0165-2478%2892%2990036-N&partnerID=40&md5=9d34a8da7c56d892f83ae3cdfcdf56f2

188.

Kalinkovich A, Engelmann H, Harpaz N, Burstein R, Barak V, Kalickman I, et al. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clinical and Experimental Immunology [Internet]. 1992;89(3):351–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026674780&doi=10.1111%252fj.1365-2249.1992.tb06961.x&partnerID=40&md5=30b541402bc7afa8d4a34cf9a7150bd1

189.

Roisman I, Barak V, Robinson E, Okon E, Livni N, Manny J, et al. Breast malignancies in adolescents in Israel (1967-1989). Breast Disease [Internet]. 1992;5(3):149–68. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026653856&partnerID=40&md5=d8f3b3c155c1924bf34f4c3dd397c894

190.

Barak V, Mordel N, Holzer H, Zajicek G, Treves AJ, Laufer N. The correlation of interleukin 1 and tumour necrosis factor to oestradiol, progesterone and testosterone levels in periovulatory follicular fluid of in-vitro fertilization patients. Human Reproduction [Internet]. 1992;7(4):462–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026561035&doi=10.1093%252foxfordjournals.humrep.a137670&partnerID=40&md5=748515f2d96aff0f743538ae6e40424b

191.

Peled T, Rigel M, Peritt D, Fibach E, Treves AJ, Barak V. Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors. Blood [Internet]. 1992;79(5):1172–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026557462&doi=10.1182%252fblood.v79.5.1172.bloodjournal7951172&partnerID=40&md5=61dd6cb36080373d13d37a29dda1d3ae

192.

Mordel N, Anteby SO, Zajicek G, Roisman I, Treves A, Barak V. CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients. Fertility and Sterility [Internet]. 1992;57(2):377–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026540890&doi=10.1016%2fS0015-0282%2816%2954849-3&partnerID=40&md5=721c619c3ffc4089b1609e5b73e9018a

193.

Barak V, Peritt D, Flechner I, Yanai P, Halperin T, Treves AJ, et al. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist. Lymphokine and Cytokine Research [Internet]. 1991;10(6):437–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026341998&partnerID=40&md5=38fe2370c33730b7d2a7b4642f5c8d45

194.

Roisman I, Gimmon Z, Barak V, Shoshani O, Lifshitz I, Barzilai M, et al. Breast developmental disorders and masses in childhood and adolescence. Harefuah [Internet]. 1991;121(11):463–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026297267&partnerID=40&md5=56fbb463b20f7024ea67b587e123a186

195.

Roisman I, Barak V, Okon E, Manny J, Durst AL. Benign cystosarcoma phyllodes of breast in an adolescent female. Breast Disease [Internet]. 1991;4(4):299–305. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025833947&partnerID=40&md5=5c3ce6fd3c64a63697496b853db54e0b

196.

Friedman G, Barak V, Chajek-Shaul T, Etienne J, Treves AJ, Stein O, et al. Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. BBA - Gene Structure and Expression [Internet]. 1991;1089(1):83–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025868856&doi=10.1016%2f0167-4781%2891%2990088-4&partnerID=40&md5=e8a60e2de2b2d7c66a136550254bdec7

197.

Roisman I, Barak V, Okon E, Sherman Y, Libson E, Durst AL. Adenolipoma of breast. Breast Disease [Internet]. 1991;4(2):153–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025729720&partnerID=40&md5=5d9f897582792d7f2fb6983da322d236

198.

Roisman I, Gimmon Z, Barak V, Durst AL. Appropriate diagnostic steps for proper clinical evaluation of breast lesions in the community. Harefuah [Internet]. 1991;120(5):266–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026133660&partnerID=40&md5=51e6627704f3c6fb4edfed3a160d3500

199.

Roisman I, Gimon Z, Barak V, Manny J. Clinical applicability of intraperitoneal administration of nutrients and drugs. Harefuah [Internet]. 1991;120(2):76–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026424230&partnerID=40&md5=7743a2269f7b52f7410c4597a73c37ae

200.

Mandelbaum-Shavit F, Barak V, Saheb-Tamimi K, Grossowicz N. Susceptibility of Legionella pneumophila grown extracellularly and in human monocytes to indole-3-propionic acid. Antimicrobial Agents and Chemotherapy [Internet]. 1991;35(12):2526–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025996388&doi=10.1128%252fAAC.35.12.2526&partnerID=40&md5=3f3a02805b54a756c83cb6617db6969b

201.

Gez E, Strauss N, Catane R, Roisman I, Barak V. The correlation between tumor response, serum prostatic-specific antigen and prostatic acid phosphatase in prostatic carcinoma patients receiving hormonetherapy. Journal of Tumor Marker Oncology [Internet]. 1991;6(1):45–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025914370&partnerID=40&md5=36dc2fd98613594c80d7f09832953a25

202.

Roisman I, Barak V, Manny J, Libson E, Wygoda M, Neuman A, et al. Fat necrosis below musculocutaneous flap mimicking carcinoma of breast. Annals of Plastic Surgery [Internet]. 1991;26(5):479–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025825881&doi=10.1097%252f00000637-199105000-00013&partnerID=40&md5=ccc43c9f2c54541d0c9210c30a0b54fc

203.

Meirow D, Anteby SO, Ehrenfeld M, Barak V, Pras M. Serum CA-125 in familial mediterranean fever peritonitis. Journal of Tumor Marker Oncology [Internet]. 1991;6(1):31–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025813539&partnerID=40&md5=e86a8b5ea7cc3680cf28947c33bf636e

204.

Ben‐Ishay Z, Barak V, Shoshan S, Prindull G. Bone marrow stromal elements in murine leukemia: Decreased CSF‐producing fibroblasts and normal IL‐1 expression by macrophages. European Journal of Haematology [Internet]. 1990;45(4):203–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025119223&doi=10.1111%252fj.1600-0609.1990.tb00458.x&partnerID=40&md5=e0486c869119b7ebb6bcd27391180489

205.

Roizman I, Gimon Z, Barak V. Breast cancer and pregnancy. Harefuah [Internet]. 1989;117(12):441–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024971918&partnerID=40&md5=80202d29250284f5757378d0a47114e2

206.

Roisman I, Gimon Z, Barak V. Male breast cancer. Harefuah [Internet]. 1989;117(3–4):68–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024713223&partnerID=40&md5=23f463c4dee24e0714f9a216617c4e5f

207.

Ovadia H, Abramsky O, Barak V, Conforti N, Saphier D, Weidenfeld J. Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats. Experimental Brain Research [Internet]. 1989;76(1):246–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024379744&doi=10.1007%252fBF00253643&partnerID=40&md5=9a78a241a0d6a5ac14b09c2bcadde7cb

208.

Roisman I, Barak V, Fields S, Bloom R, Okon E, Manny J. Solitary nonparasitic cyst of the liver: A rare cause of abdominal distension. American Journal of Gastroenterology [Internet]. 1989;84(9):1095–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024419204&partnerID=40&md5=d2770c1648e428799d4de4b2b370384d

209.

Barak V, Carlin D, Sulkes A, Treves A, Biran S. CA15-3 serum levels in breast cancer and other malignancies. Correlation with clinical course. Israel Journal of Medical Sciences [Internet]. 1988;24(9–10):623–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024246455&partnerID=40&md5=3b627a7c50e104b1fe37ff47047fd1a2

210.

Polliack A, Leizerowitz R, Barak V, Treves AJ, Gazitt Y. Effects of retinoic acid and phorbol ester on lymphocytes and monocytes in B-lymphocytic leukemia. Israel Journal of Medical Sciences [Internet]. 1988;24(9–10):522–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024239809&partnerID=40&md5=2e48b7d1d57ca4ae9bf9c7ebf3fa9dbd

211.

Barak V, Biran S, Halimi M, Treves AJ. The effect of estradiol on human myelomonocytic cells. II. Mechanism of enhancing activity of colony formation. Journal of Reproductive Immunology [Internet]. 1986;9(4):355–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023001392&doi=10.1016%2f0165-0378%2886%2990035-5&partnerID=40&md5=7c14011fe55e4672f63e91fd7532e5d8

212.

Barak V, Yamin M, Braun S, Halperin M, Biran S, Milner Y, et al. Detection of different interleukin-1 activities in human monocytes and monocytic cell lines. Journal of Biological Response Modifiers [Internet]. 1986;5(4):362–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022994726&partnerID=40&md5=57ada27541122f051c73eff0ee459f3c

213.

Barak V, Treves AJ, Yanai P, Halperin M, Wasserman D, Biran S, et al. Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). European Journal of Immunology [Internet]. 1986;16(11):1449–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022971736&doi=10.1002%252feji.1830161122&partnerID=40&md5=cd946fd4bd60f91b95474176a1d18590

214.

Maoz H, Polliack A, Barak V, Yatziv S, Biran S, Giloh H, et al. Parameters affecting the in vitro maturation of human monocytes to macrophages. The International Journal of Cell Cloning [Internet]. 1986;4(3):167–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022653373&doi=10.1002%252fstem.5530040303&partnerID=40&md5=f563673cfd61c2fe9094f53eecad6a7f

215.

Treves AJ, Barak V, Halperin M, Biran S, Leizerowitz R, Polliack A. In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. Immunology Letters [Internet]. 1986;12(4):225–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022595326&doi=10.1016%2f0165-2478%2886%2990008-8&partnerID=40&md5=8a4071a9deb1e95f0489e611e72bca5e

216.

Treves AJ, Halperin M, Barak V, Bar-Tana R, Halimi M, Fibach E, et al. A new myelomonoblastic cell line (M20): Analysis of properties, differentiation, and comparison with other established lines of similar origin. Experimental Hematology [Internet]. 1985;13(4):281–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021824678&partnerID=40&md5=f73980ecf3f37c502437aee477f4e07c

217.

Maoz H, Kaiser N, Halimi M, Barak V, Haimovitz A, Weinstein D, et al. The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. Journal of Reproductive Immunology [Internet]. 1985;7(4):325–35. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021821652&doi=10.1016%2f0165-0378%2885%2990027-0&partnerID=40&md5=96a080a01dd3761134ba1e8787076191

218.

Treves AJ, Fuks Z, Voss R, Tal T, Barak V, Konijn AM, et al. Establishment of cell lines from somatic cell hybrids between human monocytes and mouse myeloma cells. Journal of Immunology [Internet]. 1984;132(2):690–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021357366&partnerID=40&md5=7880efbedc66cd7b50e1f8458315e475

219.

Barak V, Fuks Z, Galilli N, Treves AJ. Selection and continuous growth of antigen‐specific human T cells by antigen‐treated monocytes. European Journal of Immunology [Internet]. 1983;13(11):952–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021054156&doi=10.1002%252feji.1830131116&partnerID=40&md5=bcb031c5ffc24f71c12510ab2ac5e0aa

220.

Treves AJ, Barak V, Tal T, Fuks Z. Constitutive secretion of interleukin 1 by human monocytes. European Journal of Immunology [Internet]. 1983;13(8):647–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020618091&doi=10.1002%252feji.1830130808&partnerID=40&md5=c145520d1ca19a389924db739bfc5d14

221.

Treves AJ, Tal T, Barak V, Fuks Z. Antigen presentation and regulatory functions of human monocytes in the in vitro response of lymphocytes against purified protein derivative of tuberculin (PPD). European Journal of Immunology [Internet]. 1981;11(6):487–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019404421&doi=10.1002%252feji.1830110609&partnerID=40&md5=054ce5ef218bd7126de8b01005c7e782

222.

Treves AJ, Barak V, Fuks Z. Characterization of human lymphocytes which proliferate “spontaneously” in vitro. European Journal of Immunology [Internet]. 1980;10(11):883–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019181227&doi=10.1002%252feji.1830101114&partnerID=40&md5=ee0adf45550db5f5c92f09f448a5bb52

223.

Treves AJ, Barak V, Fuks Z. In vitro proliferation of macrophage depleted human peripheral blood lymphocytes. Clinical and Experimental Immunology [Internet]. 1979;38(3):531–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018601006&partnerID=40&md5=45f60839dcbab0764e683db055842c84